Literature DB >> 25249901

2-[(4,6-Di-amino-pyrimidin-2-yl)sulfan-yl]-N-(2-methyl-phen-yl)acetamide.

S Subasri1, Timiri Ajay Kumar2, Barji Nayan Sinha2, Venkatesh Jayaprakash2, Devadasan Velmurugan1.   

Abstract

In the title compound, C13H15NOS, the plane of the n class="Chemical">pyrimidine ring makes a dihedral angle of 54.73 (9)° with that of the o-tolyl ring. The mol-ecule adopts an extended conformation, which is evident from the C-C(=O)-N-Car (ar = aromatic) torsion angle of 178.42 (15)°. In the crystal, mol-ecules are linked via pairs of N-H⋯N hydrogen bonds, forming inversion dimers with an R (2) 2(8) ring motif. The dimers are linked by N-H⋯O and C-H⋯O hydrogen bonds, with the O atom accepting three such interactions, forming sheets parallel to (100).

Entities:  

Keywords:  crystal structure

Year:  2014        PMID: 25249901      PMCID: PMC4158502          DOI: 10.1107/S1600536814015256

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the synthesis of the title compound, see: Xu et al. (2010 ▶). For the biological activity of pyrimidine derivatives, see: Hocková et al. (2003 ▶, 2004 ▶); Perales et al. (2011 ▶); Xu et al. (2010 ▶).

Experimental

Crystal data

C13H15N5OS M = 289.36 Monoclinic, a = 22.782 (5) Å b = 7.144 (5) Å c = 8.857 (5) Å β = 100.189 (5)° V = 1418.8 (13) Å3 Z = 4 Mo Kα radiation μ = 0.23 mm−1 T = 293 K 0.30 × 0.25 × 0.20 mm

Data collection

Bruker SMART APEXII area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2008 ▶) T min = 0.687, T max = 0.746 12825 measured reflections 3417 independent reflections 2654 reflections with I > 2σ(I) R int = 0.025

Refinement

R[F 2 > 2σ(F 2)] = 0.039 wR(F 2) = 0.128 S = 1.02 3417 reflections 182 parameters H-atom parameters constrained Δρmax = 0.25 e Å−3 Δρmin = −0.23 e Å−3 Data collection: APEX2 (Bruker, 2008 ▶); cell refinement: SAINT (Bruker, 2008 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012 ▶); software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009 ▶). Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536814015256/su2743sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536814015256/su2743Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S1600536814015256/su2743Isup3.cml CCDC reference: 1010947 Additional supporting information: crystallographic information; 3D view; checkCIF report
C13H15N5OSZ = 4
Mr = 289.36F(000) = 608
Monoclinic, P21/cDx = 1.355 Mg m3
Hall symbol: -P 2ybcMo Kα radiation, λ = 0.71073 Å
a = 22.782 (5) ŵ = 0.23 mm1
b = 7.144 (5) ÅT = 293 K
c = 8.857 (5) ÅBlock, colourless
β = 100.189 (5)°0.30 × 0.25 × 0.20 mm
V = 1418.8 (13) Å3
Bruker SMART APEXII area-detector diffractometer3417 independent reflections
Radiation source: fine-focus sealed tube2654 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.025
ω and φ scansθmax = 28.4°, θmin = 1.8°
Absorption correction: multi-scan (SADABS; Bruker, 2008)h = −30→30
Tmin = 0.687, Tmax = 0.746k = −9→8
12825 measured reflectionsl = −11→11
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.039Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.128H-atom parameters constrained
S = 1.02w = 1/[σ2(Fo2) + (0.0743P)2 + 0.1678P] where P = (Fo2 + 2Fc2)/3
3417 reflections(Δ/σ)max = 0.001
182 parametersΔρmax = 0.25 e Å3
0 restraintsΔρmin = −0.23 e Å3
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
C10.44402 (7)−0.1657 (2)1.14271 (18)0.0541 (4)
C20.40616 (8)−0.2557 (2)1.22577 (18)0.0565 (4)
H20.4169−0.36871.27510.068*
C30.35231 (7)−0.1729 (2)1.23308 (15)0.0479 (4)
C40.37612 (6)0.06758 (19)1.08993 (15)0.0428 (3)
C50.29403 (7)0.3577 (2)1.06689 (17)0.0498 (4)
H5A0.29100.29071.16040.060*
H5B0.29580.49051.09020.060*
C60.23955 (7)0.3184 (2)0.94817 (15)0.0450 (3)
C70.15591 (7)0.0929 (3)0.88301 (19)0.0600 (4)
C80.12155 (9)0.1991 (4)0.7684 (3)0.0836 (7)
H80.13350.31920.74710.100*
C90.06952 (10)0.1246 (5)0.6865 (3)0.1038 (9)
H90.04670.19450.60890.125*
C100.05148 (10)−0.0489 (5)0.7182 (3)0.1083 (9)
H100.0161−0.09740.66360.130*
C110.08558 (10)−0.1541 (4)0.8317 (3)0.0879 (7)
H110.0727−0.27340.85240.105*
C120.13842 (7)−0.0871 (3)0.9157 (2)0.0623 (5)
C130.17501 (10)−0.2061 (3)1.0374 (2)0.0705 (5)
H13A0.1746−0.15201.13640.106*
H13B0.2153−0.21221.01960.106*
H13C0.1585−0.33001.03390.106*
N10.42970 (6)0.00314 (17)1.07572 (14)0.0492 (3)
N20.33525 (5)−0.01003 (16)1.15794 (12)0.0447 (3)
N30.31124 (7)−0.2447 (2)1.31032 (16)0.0624 (4)
H3A0.2779−0.18771.30880.075*
H3B0.3185−0.34741.36090.075*
N40.49728 (8)−0.2346 (3)1.1248 (2)0.0820 (5)
H4A0.5195−0.17231.07380.098*
H4B0.5091−0.34101.16430.098*
N50.20923 (6)0.1643 (2)0.97155 (15)0.0572 (4)
H50.22400.09951.05110.069*
O10.22618 (6)0.42293 (18)0.83847 (13)0.0687 (4)
S10.361751 (18)0.28855 (6)1.00258 (5)0.05785 (16)
U11U22U33U12U13U23
C10.0596 (9)0.0472 (9)0.0498 (8)0.0097 (7)−0.0054 (7)0.0037 (7)
C20.0738 (11)0.0425 (8)0.0486 (8)0.0117 (8)−0.0017 (7)0.0092 (6)
C30.0688 (10)0.0384 (7)0.0326 (6)0.0011 (7)−0.0014 (6)−0.0002 (5)
C40.0536 (8)0.0356 (7)0.0345 (6)0.0012 (6)−0.0054 (5)−0.0015 (5)
C50.0628 (9)0.0354 (7)0.0490 (8)0.0060 (7)0.0039 (6)−0.0007 (6)
C60.0508 (8)0.0444 (8)0.0414 (7)0.0090 (6)0.0124 (6)0.0012 (6)
C70.0461 (8)0.0792 (12)0.0535 (9)−0.0016 (8)0.0058 (7)0.0023 (8)
C80.0543 (11)0.1116 (18)0.0796 (13)−0.0008 (11)−0.0025 (9)0.0239 (12)
C90.0571 (12)0.160 (3)0.0862 (15)−0.0027 (16)−0.0096 (10)0.0175 (17)
C100.0581 (13)0.165 (3)0.0938 (17)−0.0216 (16)−0.0090 (11)−0.0151 (18)
C110.0645 (12)0.1092 (18)0.0881 (14)−0.0245 (12)0.0087 (11)−0.0199 (14)
C120.0539 (9)0.0765 (13)0.0579 (9)−0.0093 (9)0.0139 (7)−0.0114 (8)
C130.0777 (13)0.0576 (11)0.0757 (12)−0.0109 (9)0.0124 (10)−0.0059 (9)
N10.0530 (7)0.0419 (7)0.0487 (7)0.0059 (6)−0.0023 (5)0.0030 (5)
N20.0585 (7)0.0362 (6)0.0365 (6)0.0039 (5)0.0002 (5)0.0000 (5)
N30.0830 (11)0.0503 (8)0.0549 (8)0.0077 (7)0.0146 (7)0.0147 (6)
N40.0690 (11)0.0739 (11)0.1029 (14)0.0298 (9)0.0151 (9)0.0318 (10)
N50.0551 (8)0.0603 (8)0.0521 (7)−0.0044 (6)−0.0020 (6)0.0133 (6)
O10.0780 (8)0.0694 (8)0.0540 (7)−0.0050 (6)−0.0013 (6)0.0188 (6)
S10.0529 (3)0.0455 (3)0.0740 (3)0.00657 (17)0.00824 (19)0.02046 (18)
C1—N41.345 (2)C7—N51.419 (2)
C1—N11.358 (2)C8—C91.382 (3)
C1—C21.387 (3)C8—H80.9300
C2—C31.374 (2)C9—C101.351 (4)
C2—H20.9300C9—H90.9300
C3—N31.354 (2)C10—C111.379 (4)
C3—N21.3625 (19)C10—H100.9300
C4—N21.317 (2)C11—C121.384 (3)
C4—N11.3312 (19)C11—H110.9300
C4—S11.7630 (17)C12—C131.504 (3)
C5—C61.505 (2)C13—H13A0.9600
C5—S11.8054 (17)C13—H13B0.9600
C5—H5A0.9700C13—H13C0.9600
C5—H5B0.9700N3—H3A0.8600
C6—O11.2207 (18)N3—H3B0.8600
C6—N51.335 (2)N4—H4A0.8600
C7—C81.392 (3)N4—H4B0.8600
C7—C121.392 (3)N5—H50.8600
N4—C1—N1115.18 (16)C8—C9—H9119.7
N4—C1—C2123.50 (16)C9—C10—C11119.9 (2)
N1—C1—C2121.30 (15)C9—C10—H10120.0
C3—C2—C1118.03 (15)C11—C10—H10120.0
C3—C2—H2121.0C10—C11—C12121.9 (3)
C1—C2—H2121.0C10—C11—H11119.1
N3—C3—N2114.04 (15)C12—C11—H11119.1
N3—C3—C2124.29 (14)C11—C12—C7117.5 (2)
N2—C3—C2121.65 (15)C11—C12—C13120.6 (2)
N2—C4—N1129.18 (13)C7—C12—C13121.89 (16)
N2—C4—S1119.08 (11)C12—C13—H13A109.5
N1—C4—S1111.74 (11)C12—C13—H13B109.5
C6—C5—S1111.95 (10)H13A—C13—H13B109.5
C6—C5—H5A109.2C12—C13—H13C109.5
S1—C5—H5A109.2H13A—C13—H13C109.5
C6—C5—H5B109.2H13B—C13—H13C109.5
S1—C5—H5B109.2C4—N1—C1114.78 (14)
H5A—C5—H5B107.9C4—N2—C3114.77 (13)
O1—C6—N5124.40 (15)C3—N3—H3A120.0
O1—C6—C5120.05 (14)C3—N3—H3B120.0
N5—C6—C5115.54 (13)H3A—N3—H3B120.0
C8—C7—C12120.68 (18)C1—N4—H4A120.0
C8—C7—N5121.56 (19)C1—N4—H4B120.0
C12—C7—N5117.76 (15)H4A—N4—H4B120.0
C9—C8—C7119.5 (2)C6—N5—C7128.79 (14)
C9—C8—H8120.2C6—N5—H5115.6
C7—C8—H8120.2C7—N5—H5115.6
C10—C9—C8120.6 (2)C4—S1—C5102.08 (8)
C10—C9—H9119.7
N4—C1—C2—C3−178.67 (16)N5—C7—C12—C13−1.6 (3)
N1—C1—C2—C32.8 (2)N2—C4—N1—C1−0.8 (2)
C1—C2—C3—N3−179.76 (15)S1—C4—N1—C1179.04 (11)
C1—C2—C3—N21.9 (2)N4—C1—N1—C4177.99 (14)
S1—C5—C6—O1−78.22 (17)C2—C1—N1—C4−3.3 (2)
S1—C5—C6—N5100.79 (14)N1—C4—N2—C35.1 (2)
C12—C7—C8—C90.1 (3)S1—C4—N2—C3−174.73 (9)
N5—C7—C8—C9−179.1 (2)N3—C3—N2—C4176.08 (12)
C7—C8—C9—C100.9 (4)C2—C3—N2—C4−5.39 (19)
C8—C9—C10—C11−0.9 (5)O1—C6—N5—C7−2.6 (3)
C9—C10—C11—C120.0 (4)C5—C6—N5—C7178.42 (15)
C10—C11—C12—C70.9 (3)C8—C7—N5—C6−11.7 (3)
C10—C11—C12—C13−179.2 (2)C12—C7—N5—C6169.09 (16)
C8—C7—C12—C11−0.9 (3)N2—C4—S1—C59.30 (12)
N5—C7—C12—C11178.33 (17)N1—C4—S1—C5−170.54 (10)
C8—C7—C12—C13179.20 (19)C6—C5—S1—C4−98.07 (12)
D—H···AD—HH···AD···AD—H···A
N4—H4A···N1i0.862.263.115 (2)175
N3—H3A···O1ii0.862.273.045 (2)150
N5—H5···O1ii0.862.543.264 (3)142
C13—H13A···O1ii0.962.553.385 (3)145
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
N4—H4A⋯N1i 0.862.263.115 (2)175
N3—H3A⋯O1ii 0.862.273.045 (2)150
N5—H5⋯O1ii 0.862.543.264 (3)142
C13—H13A⋯O1ii 0.962.553.385 (3)145

Symmetry codes: (i) ; (ii) .

  5 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma brucei.

Authors:  Joe B Perales; Jennifer Freeman; Cyrus J Bacchi; Tana Bowling; Robert Don; Eric Gaukel; Luke Mercer; Joseph A Moore; Bakela Nare; Tien M Nguyen; Robert A Noe; Ryan Randolph; Cindy Rewerts; Stephen A Wring; Nigel Yarlett; Robert T Jacobs
Journal:  Bioorg Med Chem Lett       Date:  2011-04-01       Impact factor: 2.823

3.  Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds.

Authors:  Dana Hocková; Antonín Holý; Milena Masojídková; Graciela Andrei; Robert Snoeck; Erik De Clercq; Jan Balzarini
Journal:  Bioorg Med Chem       Date:  2004-06-15       Impact factor: 3.641

4.  5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity.

Authors:  Dana Hocková; Antonín Holý; Milena Masojídková; Graciela Andrei; Robert Snoeck; Erik De Clercq; Jan Balzarini
Journal:  J Med Chem       Date:  2003-11-06       Impact factor: 7.446

5.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  5 in total
  5 in total

1.  Crystal structures of 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-N-(3-nitro-phen-yl)acetamide monohydrate and N-(2-chloro-phen-yl)-2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]acetamide.

Authors:  S Subasri; Ajay Kumar Timiri; Nayan Sinha Barji; Venkatesan Jayaprakash; Viswanathan Vijayan; Devadasan Velmurugan
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-07-22

2.  Crystal structures of 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-N-(naphthalen-1-yl)acetamide and 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-N-(4-fluoro-phen-yl)acetamide.

Authors:  S Subasri; Timiri Ajay Kumar; Barij Nayan Sinha; Venkatesan Jayaprakash; Vijayan Viswanathan; Devadasan Velmurugan
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-01-31

3.  Crystal structures of 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-N-(2,4-di-methyl-phen-yl)acetamide and 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-N-(3-meth-oxy-phen-yl)acetamide.

Authors:  Manisha Choudhury; Vijayan Viswanathan; Ajay Kumar Timiri; Barij Nayan Sinha; Venkatesan Jayaprakash; Devadasan Velmurugan
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-06-13

4.  Crystal structures and Hirshfeld surface analyses of 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-N-(pyridin-2-yl)acetamide and 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-N-(pyrazin-2-yl)acetamide.

Authors:  Manisha Choudhury; Vijayan Viswanathan; Ajay Kumar Timiri; Barij Nayan Sinha; Venkatesan Jayaprakash; Devadasan Velmurugan
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-04-27

5.  Crystal structure and Hirshfeld surface analysis of 2-[(1,3-benzoxazol-2-yl)sulfan-yl]-N-(2-meth-oxy-phen-yl)acetamide.

Authors:  Abdullah Aydin; Sevim Turktekin Celikesir; Mehmet Akkurt; Merve Saylam; Varol Pabuccuoglu
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2019-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.